Hello! You're looking at a policy document report on Overton

We track government policy, guidelines, think tank research, working papers and more to help our customers see the impact and influence of their work. Are you interested in seeing what information we have to offer? Request a free trial to our platform.

If you fund, produce or manage research or work to influence policy, we'd love to talk. Learn more on our homepage.

Risk assessment: Outbreak of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): increased transmission beyond China fourth update

European Centre for Disease Prevention and Control on February 15th 2020

On 31 December 2019, a cluster of pneumonia cases of unknown aetiology was reported in Wuhan, Hubei Province, China. On 9 January 2020, China CDC reported a novel coronavirus as the causative agent of this outbreak, which is phylogenetically in the SARS-CoV clade. The novel coronavirus has thus been named ‘severe acute respiratory syndrome coronavirus 2’ (SARS-CoV-2), while coronavirus disease associated with it is now referred to as COVID-19.

See the 23 policy documents that cite this document

See report on the 23 policy documents that cite this document

See the 22 articles cited by this document

See report on the 22 articles cited by this document

Topics in this document

Medical humanities Epidemiology Health sciences Clinical medicine Medical specialties Medicine Health Social distancing Infection Severe acute respiratory syndrome Middle East respiratory syndrome-related coronavirus Severe acute respiratory syndrome coronavirus Influenza Transmission (medicine) Surgical mask Coronavirus Health care Infection control Severe acute respiratory syndrome-related coronavirus Public health Health professional Risk Emergency management Personal protective equipment Severe acute respiratory syndrome coronavirus 2 Diseases and disorders European Centre for Disease Prevention and Control Disease Screening (medicine) Virus

Related SDGs

Cites research funded by

3 MRC 1 National Key R&D Program of China 1 Government of the Hong Kong Special Administrative Region 1 National Science Fund for Distinguished Young Scholars 1 China-US Collaborative Program on Emerging and Re-emerging Infectious Disease 1 National Science and Technology Major Project of China 1 the Harvard Center for Communicable Disease Dynamics from the National Institute of General Medical Sciences 1 Joint Fund of Coal 1 Terumo BCT 1 Terumo 1 FP7_REST_SecondPillar (Special project, May 2022) 1 FP7_REST_ALL (Special project, May 2022) 2 NIHR (November 2024) 1 Swiss National Science Foundation 1 ESRC January 2022 1 ESRC 1 Wellcome Trust 1 Medical Research Council 1 National Institute for Health Research (NIHR)

Citations

Cited by 23 other policy documents (18 of them are from other policy sources)

overton